ES2036661T3 - Un metodo para preparar una preparacion farmaceutica de pie de atleta. - Google Patents

Un metodo para preparar una preparacion farmaceutica de pie de atleta.

Info

Publication number
ES2036661T3
ES2036661T3 ES198888120481T ES88120481T ES2036661T3 ES 2036661 T3 ES2036661 T3 ES 2036661T3 ES 198888120481 T ES198888120481 T ES 198888120481T ES 88120481 T ES88120481 T ES 88120481T ES 2036661 T3 ES2036661 T3 ES 2036661T3
Authority
ES
Spain
Prior art keywords
pharmaceutical preparation
athlete
foot
prepare
plasticizer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888120481T
Other languages
English (en)
Inventor
Izumi Saitoh
Kaori Ikeda
Shigeru Kido
Yoshio Doi
Shohei Egawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2036661T3 publication Critical patent/ES2036661T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PREPARACION FARMACEUTICA PARA EL TRATAMIENTO DE LA TINEA PEDIS, QUE CONTIENE COMO COMPONENTES BASICOS DE 0.1 A 2.5% DE HIDROCLORURO DE CROCONAZOL Y DE 1 A 15% DE UN COPOLIMERO DE ACRILATO DE ETILO - METACRILATO DE METILO EN SOLUCION HIDROALCOHOLICA, OPCIONALMENTE JUNTO CON 0.1 A 2.5% DE UN AGENTE ESPESANTE Y/O UN PLASTIFICANTE.
ES198888120481T 1987-12-08 1988-12-07 Un metodo para preparar una preparacion farmaceutica de pie de atleta. Expired - Lifetime ES2036661T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62310479A JPH0818983B2 (ja) 1987-12-08 1987-12-08 水虫治療剤

Publications (1)

Publication Number Publication Date
ES2036661T3 true ES2036661T3 (es) 1993-06-01

Family

ID=18005734

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888120481T Expired - Lifetime ES2036661T3 (es) 1987-12-08 1988-12-07 Un metodo para preparar una preparacion farmaceutica de pie de atleta.

Country Status (8)

Country Link
US (1) US4935241A (es)
EP (1) EP0319965B1 (es)
JP (1) JPH0818983B2 (es)
KR (1) KR960009415B1 (es)
AT (1) ATE61522T1 (es)
DE (1) DE3862017D1 (es)
ES (1) ES2036661T3 (es)
GR (1) GR3001862T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0794378B2 (ja) * 1989-08-18 1995-10-11 久光製薬株式会社 エアゾール剤
AUPO379596A0 (en) * 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
US20030228382A1 (en) * 2002-06-06 2003-12-11 Dr. Ivar Roth Foot Fixer Kit
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
DK1931309T3 (da) 2005-09-29 2013-01-02 Novartis Ag Antimykotisk sammensætning
ES2591030T3 (es) * 2007-09-05 2016-11-24 Pola Pharma Inc. Composición farmacéutica antifúngica
CA2719512A1 (en) 2010-11-01 2012-05-01 Stiefel Research Australia Pty Ltd Polymeric topical compositions
JP2014515365A (ja) * 2011-05-26 2014-06-30 ノバルティス アーゲー 生理学的活性剤の経皮投与のための組成物
KR101457789B1 (ko) 2013-02-13 2014-11-03 동아제약 주식회사 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619826A (en) * 1983-05-23 1986-10-28 The Dow Chemical Company Acne control method
GB8607159D0 (en) * 1986-03-22 1986-04-30 Smith & Nephew Ass Pharmaceutical composition

Also Published As

Publication number Publication date
US4935241A (en) 1990-06-19
JPH0818983B2 (ja) 1996-02-28
GR3001862T3 (en) 1992-11-23
EP0319965A1 (en) 1989-06-14
ATE61522T1 (de) 1991-03-15
DE3862017D1 (de) 1991-04-18
KR960009415B1 (ko) 1996-07-19
EP0319965B1 (en) 1991-03-13
KR890009391A (ko) 1989-08-01
JPH01149725A (ja) 1989-06-12

Similar Documents

Publication Publication Date Title
NO865093D0 (no) Fremgangsmaate for fremstilling av n,n-dimetyl-1-(1-(4-klorfenyl)cyklobutyl)-3-metylbutylamin.
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
DE3587941D1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
NO870241L (no) Hypoglykemiske tiazolidindioner.
YU22794A (sh) Veterinarska kompozicija
EA200300503A1 (ru) Новые лекарственные композиции на основе солей тиотропия и солей салметерола
DE69025920D1 (de) Glykosaminoglykan-modifiertes Protein, Verfahren zu dessen Herstellung und pharmazeutische Zubereitungen, die es enthalten
DK324185A (da) 2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
ES2036661T3 (es) Un metodo para preparar una preparacion farmaceutica de pie de atleta.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
ES2061826T3 (es) Un procedimiento de preparacion de derivados n-2,3-butadienil triaminoalcanos.
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
EA200401303A1 (ru) Лекарственные средства, содержащие стероиды и новое антихолинергическое средство
DE3875611D1 (de) Pharmazeutische zusammensetzungen.
FR2618677B1 (fr) Composition pharmaceutique destinee a la prevention et au traitement des maladies bacteriennes ou virales
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
DK528386A (da) Proteinabsorptionsforoegende midler
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
SE7806469L (sv) Antihypertensiva kompositioner
IT8520736A0 (it) Composizione medicinale e metodo per la cura delle periartriti ed affezioni similari.
ATE81983T1 (de) Absorptionsverbesserer fuer proteine.
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 319965

Country of ref document: ES